pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

6,271 catalysts · 6,271 phase readout · 2,337 8k filing · 390 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: grant×type: filing×clear all
type
  • phase readout6,271
  • 8k filing2,337
  • earnings390
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07414992: A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Bladder Urothelial Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT03222492: Brentuximab Vedotin for Systemic Sclerosis

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Diffuse Cutaneous Systemic Sclerosis, Scleroderma, dcSSc

full page →ctgov ↗
›COMPLETEDphase readoutNCT05311592: Supporting Responsible Fatherhood Program (Fatherhood FIRE)

Sponsor: Montefiore Medical Center. Phase: NA. Conditions: Parenting, Family Relations, Father-Child Relations

full page →ctgov ↗
›RECRUITINGphase readoutNCT07579936: A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.. Phase: PHASE2. Conditions: Postmenopausal Women With Osteoporosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07473700: Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

Sponsor: Tectonic Operating Company, Inc.. Phase: PHASE2. Conditions: Hypertension, Pulmonary, Lung Diseases, Interstitial

full page →ctgov ↗
›RECRUITINGphase readoutNCT07411807: Study of the Effectiveness of a Systematic Minimal Early Intervention on Care Engagement in Adults With Eating Disorders Requesting Specialized Treatment.

Sponsor: Centre Hospitalier St Anne. Phase: NA. Conditions: Eating Disorders

full page →ctgov ↗
›RECRUITINGphase readoutNCT07597707: Investigating Health, Equity, and Resilience in Girls and Women With ADHD Across the Lifespan

Sponsor: University of Calgary. Phase: . Conditions: ADHD

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07569107: Learning Curve Analysis of Double-Lumen Tube Placement in Anesthesiology Residents: The Impact of Prior Experience and Laryngoscope Type

Sponsor: Ankara Ataturk Sanatorium Training and Research Hospital. Phase: . Conditions: Learning Curves and Outcomes of Simulation-based Training, Double Lumen Tube Intubation, Anesthesiology Residency Training, Experience, Laryngoscopes

full page →ctgov ↗
›RECRUITINGphase readoutNCT07667192: Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer

Sponsor: Affidea Nu-med Center of Oncological DIagnostics and Therapy. Phase: . Conditions: Recurrent Gynecologic Cancer, Recurrent Uterine Cancer, Recurrent Cervical Cancer, Recurrent Vaginal Cancer, Recurrent Vulvar Cancer, Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Primary Peritoneal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07762911: Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III)

Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07599436: Laughter Yoga and Sleep Hygiene Training for College Students With Premenstrual Syndrome

Sponsor: Gazi University. Phase: NA. Conditions: Laughter Yoga, Premenstrual Syndrome-PMS, Stress, Sleep Quality

full page →ctgov ↗
›RECRUITINGphase readoutNCT07565311: Two-week Intensive Outpatient Trauma Treatment.

Sponsor: Oslo University Hospital. Phase: NA. Conditions: Posttraumatic Stress Disorder (PTSD)

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07130500: Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization

Sponsor: Stanford University. Phase: NA. Conditions: Schizophrenia Disorder, Schizoaffective Disorder, Bipolar Disorder (BD), Substance Use Disorder (SUD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07698392: Dynamic Neuromuscular Stabilization Versus Corrective Exercises in Upper Cross Syndrome

Sponsor: Cairo University. Phase: NA. Conditions: Upper Crossed Syndrome, Upper Cross Syndrome, Upper Crossed Syndorme

full page →ctgov ↗
›RECRUITINGphase readoutNCT04544592: UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Sponsor: University of Colorado, Denver. Phase: PHASE1. Conditions: B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07598136: A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers

Sponsor: RAI Services Company. Phase: NA. Conditions: Smoking, Tobacco

full page →ctgov ↗
›RECRUITINGphase readoutNCT06246136: Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery

Sponsor: Elios Vision, Inc.. Phase: NA. Conditions: Open Angle Glaucoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07435636: Modulation of Stem Cell Differentiation in Individuals With High Risk Clonal Haematopoiesis

Sponsor: Clinical Hub for Interventional Research (CHOIR). Phase: PHASE2. Conditions: Clonal Cytopenia of Uncertain Significance, CCUS Clonal Cytopenia of Undetermined Significance, Clonal Hematopoiesis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07088536: Occupational Situation and Return to Work of Urological Patients

Sponsor: Jagiellonian University. Phase: . Conditions: Bladder Cancer, Prostate Cancer, Renal Cancer, Urinary Stones

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07756736: Psilocybin Therapy for Methamphetamine Use Disorder and HIV

Sponsor: Nicky Mehtani, MD, MPH. Phase: PHASE2. Conditions: Methamphetamine Use Disorder, Human Immunodeficiency Virus (HIV)

full page →ctgov ↗
›COMPLETEDphase readoutNCT00748111: Thrombus and Inflammation Study in Sudden Cardiac DEath

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Sudden Cardiac Death, Acute Myocardial Infarction

full page →ctgov ↗
›RECRUITINGphase readoutNCT06096207: DBS for Depression

Sponsor: Northwell Health. Phase: PHASE1. Conditions: Treatment Resistant Depression

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07703592: Comparison of Manual PAOP and Automatic PAOP (Smart Wedge)

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Septic Shock

full page →ctgov ↗
›COMPLETEDphase readoutNCT07561736: Comparison of Surgical Blade No. 11 and Ophthalmic Knife in Idiopathic Clubfoot Patients

Sponsor: Muhammad Aamir Latif. Phase: . Conditions: Clubfoot

full page →ctgov ↗
›COMPLETEDphase readoutNCT05947799: A Comparative Study on the Effectiveness of Video vs Text-Based Education in Heart Failure

Sponsor: Stanford University. Phase: NA. Conditions: Heart Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT07321899: Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

Sponsor: Medtronic Cardiovascular. Phase: NA. Conditions: Severe Tricuspid Regurgitation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07418398: Exoskeletal-assisted Walking Combined With Transcutaneous Spinal Cord Stimulation: Effect on Imaging and Serum Biomarkers of Skeletal Muscle Mass and Bone Strength.

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Spinal Cord Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT06370832: Inspiratory Muscle Training in Lung Transplant Candidates

Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Inspiratory Muscle Training

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07071532: A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Adult Participants With Bipolar Disorder

Sponsor: AbbVie. Phase: PHASE1. Conditions: Bipolar Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06517563: Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of Heparin

Sponsor: VarmX B.V.. Phase: PHASE1. Conditions: Coagulation Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT05171387: Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancer

Sponsor: Bayer. Phase: PHASE2. Conditions: Prostate Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06133387: PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System

Sponsor: EndoQuest Robotics, Inc.. Phase: NA. Conditions: Colorectal Lesion, Colorectal Adenoma, Colorectal Polyp, Rectal Lesion, Rectal Adenoma, Rectal Polyp, Sigmoid; Lesion, Sigmoid Colon Polyp

full page →ctgov ↗
›RECRUITINGphase readoutNCT06188793: Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients

Sponsor: University of Michigan. Phase: NA. Conditions: Inflammatory Bowel Diseases

full page →ctgov ↗
›COMPLETEDphase readoutNCT05654493: Use of Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC) for Glaucoma Patients

Sponsor: Mayo Clinic. Phase: . Conditions: Glaucoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT01282021: Molecular Immunohematology in Ethiopian Sub-Populations

Sponsor: National Institutes of Health Clinical Center (CC). Phase: . Conditions: Immunohematology

full page →ctgov ↗
›COMPLETEDphase readoutNCT07547514: The Effects of Yoga on Sensory, Motor, Cognitive Skills, and Perceived Stress in Children With Developmental Coordination Disorder

Sponsor: Fenerbahce University. Phase: NA. Conditions: Development Coordination Disorder, Motor Coordination or Function; Developmental Disorder, Sensory Integration Disorder, Perceived Stres Level, Cognitive Ability General

full page →ctgov ↗
›COMPLETEDphase readoutNCT05083416: Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome

Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: NA. Conditions: Head and Neck Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07127016: Mindfulness in Nonflaccid Facial Paralysis

Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Facial Paralysis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07652216: Bone Defects Reconstruction After Dentigerous Cyst Enucleation With Autogenous Demineralized Dentin Matrix- ADDM and Advanced Platelet-Rich Fibrin- A-PRF.

Sponsor: Jagiellonian University. Phase: NA. Conditions: Impact Molar, Mandible Cyst, Bone Regeneration, Platelet Rich Fibrin, Dentigerous Cyst, Dentin Matrix, Autogenous Dentin Graft, Demineralized Dentin Matrix, Impacted Lower Third Molar, Impacted Mandibular Third Molar

full page →ctgov ↗
›RECRUITINGphase readoutNCT06960616: Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy

Sponsor: Massachusetts Eye and Ear Infirmary. Phase: NA. Conditions: Deafness, Cochlear Hearing Loss

full page →ctgov ↗
›COMPLETEDphase readoutNCT05492006: Immune Response and Affective States of Elderly and 50+ Individuals After Intentional and Indirect Contact With Nature

Sponsor: Hospital Israelita Albert Einstein. Phase: NA. Conditions: Elderly

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07273006: Percutaneous Electrical Nerve Stimulation As Alternative To Nerve Blocks In Anesthesia, Pain Medicine And Rehabilitation Of Nonspecific Chronic Pain

Sponsor: Universidad Complutense de Madrid. Phase: PHASE4. Conditions: Non-specific Low Back Pain (NSLBP), Facet Joint Syndrome

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05736406: A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma

Sponsor: Hemerion Therapeutics. Phase: PHASE1. Conditions: Primary Glioblastoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07592806: CRISTEL Study: Monitoring of Pregnancies in Women After Solid Organ Transplantation

Sponsor: Hopital Foch. Phase: NA. Conditions: Surgical Operation With Transplant of Whole Organ

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07757204: An Open-label Long-term Safety Study of Buntanetap in Participants With AD

Sponsor: Annovis Bio Inc.. Phase: PHASE2. Conditions: Alzheimer's Dementia (AD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT06611384: Arrhythmias in Hemorrhagic Myocardial Infarction During the Acute Post-PCI Phase

Sponsor: Rohan Dharmakumar. Phase: . Conditions: Acute Myocardial Infarction

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05700084: Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors

Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT05427084: Canagliflozin Targeting Vascular Inflammation

Sponsor: Ottawa Heart Institute Research Corporation. Phase: PHASE2. Conditions: Diabetes Type 2, Coronary Artery Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT05272384: Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Hodgkin Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07374484: Longitudinal Dynamics of AT1R Antibodies in Kidney Transplant Recipients

Sponsor: Seoul National University Hospital. Phase: . Conditions: Kidney Transplantation, Graft Survival, Angiotensin II Type 1 Receptor Antibody

full page →ctgov ↗
← prev
page 125 of 126
next →